These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22924503)

  • 1. Busy period for Bristol-Myers Squibb.
    Payne T
    Future Med Chem; 2012 Sep; 4(13):1659. PubMed ID: 22924503
    [No Abstract]   [Full Text] [Related]  

  • 2. Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009.
    Zhang L; Cvijic ME; Lippy J; Myslik J; Brenner SL; Binnie A; Houston JG
    Drug Discov Today; 2012 Jul; 17(13-14):733-40. PubMed ID: 22425710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muraglitazar (Bristol-Myers Squibb/Merck).
    Barlocco D
    Curr Opin Investig Drugs; 2005 Apr; 6(4):427-34. PubMed ID: 15898350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bristol-Myers Squibb drug information department services.
    Sylvan L; Palmer-Shevlin N
    Hosp Pharm; 1995 Jan; 30(1):38-9, 44. PubMed ID: 10139729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bristol-Myers Squibb reaps biologics in ZymoGenetics windfall.
    Dorey E
    Nat Biotechnol; 2010 Nov; 28(11):1137-8. PubMed ID: 21057465
    [No Abstract]   [Full Text] [Related]  

  • 6. DPC-423 Bristol-Myers Squibb.
    Taglialatela M
    Curr Opin Investig Drugs; 2002 Feb; 3(2):252-4. PubMed ID: 12020055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bristol-Myers Squibb launches $2 million AIDS grant program.
    AIDS Read; 2000 Apr; 10(4):208. PubMed ID: 10808603
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug giant Bristol-Myers Squibb: Atazanavir moves into the spotlight while O83 bites the dust.
    Posit Aware; 2002; 13(4):42-3. PubMed ID: 12171044
    [No Abstract]   [Full Text] [Related]  

  • 9. In vogue with venture.
    Patou G
    Nat Biotechnol; 2011 Nov; 29(11):967-9. PubMed ID: 22175076
    [No Abstract]   [Full Text] [Related]  

  • 10. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
    Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW
    Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 12. BMS-193884 and BMS-207940 Bristol-Myers Squibb.
    Hulpke-Wette M; Buchhorn R
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1057-61. PubMed ID: 12186267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bristol-Myers Squibb pushes BuSpar compliance.
    Telemed Virtual Real; 1998 Dec; 3(12):144. PubMed ID: 10345193
    [No Abstract]   [Full Text] [Related]  

  • 14. AstraZeneca Pharmaceuticals enables scientific innovation.
    Cardiovasc J Afr; 2014; 25(1):40. PubMed ID: 24626520
    [No Abstract]   [Full Text] [Related]  

  • 15. eJIAS and the Bristol-Myers Squibb Foundation's Secure the Future Program.
    Damonti J
    MedGenMed; 2004 Jul; 6(3):57. PubMed ID: 15520681
    [No Abstract]   [Full Text] [Related]  

  • 16. BMS offers some relief for Africa's AIDS crisis. Bristol Myers Squibb.
    Birmingham K
    Nat Med; 1999 Jun; 5(6):599. PubMed ID: 10371487
    [No Abstract]   [Full Text] [Related]  

  • 17. The Medicines Company: an emerging pharmaceutical company in cardiology is spearheading an innovative approach to critical care medicines.
    Mayor S
    Eur Heart J; 2009 Jul; 30(13):1541-3. PubMed ID: 19579293
    [No Abstract]   [Full Text] [Related]  

  • 18. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
    [No Abstract]   [Full Text] [Related]  

  • 19. Thomas C. Sühoff, MD, of the University of Texas Southwestern Medical Center at Dallas wins Bristol-Myers Squibb Neuroscience Research Award.
    J Mol Neurosci; 2004; 24(2):329-31. PubMed ID: 15560010
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficient and effective compound management to support lead optimization.
    Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
    J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.